We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BWXT icon
5051
BWX Technologies
BWXT
$15.9B
$4K ﹤0.01%
56
-2,588
-98% -$156K
BYFC icon
5052
Broadway Financial
BYFC
$110M
$4K ﹤0.01%
476
-318
-40% -$2.99K
CARZ icon
5053
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$49.2M
$4K ﹤0.01%
79
– –
CASI
5054
DELISTED
CASI Pharmaceuticals
CASI
$4K ﹤0.01%
1,674
-1,820
-52% -$3.5K
CATX icon
5055
Perspective Therapeutics
CATX
$365M
$4K ﹤0.01%
670
-1,481
-69% -$6.05K
CIB icon
5056
Grupo Cibest SA
CIB
$22.8B
$4K ﹤0.01%
151
-1,573
-91% -$42.5K
CRBP icon
5057
Corbus Pharmaceuticals
CRBP
$195M
$4K ﹤0.01%
535
-1,350
-72% -$5.91K
ELTX icon
5058
Elicio Therapeutics
ELTX
$81.2M
$4K ﹤0.01%
621
+263
+73% +$1.75K
EMD
5059
Western Asset Emerging Markets Debt Fund
EMD
$607M
$4K ﹤0.01%
+456
New +$4.16K
ESCA icon
5060
Escalade
ESCA
$276M
$4K ﹤0.01%
265
+241
+1,004% +$3.06K
FAAR icon
5061
First Trust Alternative Absolute Return Strategy ETF
FAAR
$196M
$4K ﹤0.01%
+145
New +$4.35K
FTXR icon
5062
First Trust Nasdaq Transportation ETF
FTXR
$1.06B
$4K ﹤0.01%
+164
New +$4.53K
FXY icon
5063
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
$4K ﹤0.01%
+55
New +$3.87K
GDXJ icon
5064
VanEck Junior Gold Miners ETF
GDXJ
$8.49B
$4K ﹤0.01%
96
-2,239
-96% -$82.7K
GGLS icon
5065
Direxion Daily GOOGL Bear 1X ETF
GGLS
$16.1M
$4K ﹤0.01%
19
+12
+171% +$3.18K
GLDM icon
5066
SPDR Gold MiniShares Trust
GLDM
$30B
$4K ﹤0.01%
99
-29
-23% -$1.09K
GRI
5067
GRI Bio
GRI
$2.96M
– –
0
– –
GRNQ icon
5068
Greenpro Capital
GRNQ
$13.9M
$4K ﹤0.01%
251
-36
-13% -$507
GRPN icon
5069
Groupon
GRPN
$875M
$4K ﹤0.01%
851
-8,627
-91% -$59.6K
GTN.A icon
5070
Gray Media Inc
GTN.A
$4K ﹤0.01%
450
-113
-20% -$1.19K
GUNR icon
5071
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
$4K ﹤0.01%
99
-8,819
-99% -$384K
HOWL icon
5072
Werewolf Therapeutics
HOWL
$19.7M
$4K ﹤0.01%
1,524
-5,622
-79% -$16.8K
HSAI
5073
Hesai Group
HSAI
$2.86B
$4K ﹤0.01%
+260
New +$4.67K
HUDI icon
5074
Huadi International Group
HUDI
$13.7M
$4K ﹤0.01%
+1,326
New +$6.2K
HYEM icon
5075
VanEck Emerging Markets High Yield Bond ETF
HYEM
$528M
$4K ﹤0.01%
214
+14
+7% +$260
201 202
203
204 205

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.